TGA Approval

VSIQQ brolucizumab (rbe) 120 mg/mL solution for injection in vial (349910)

ARTG ID

349910

ARTG Name

VSIQQ brolucizumab (rbe) 120 mg/mL solution for injection in vial

Sponsor

Novartis Pharmaceuticals Australia Pty Ltd

ARTG Date

January 28, 2021

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

Novartis Pharmaceuticals Australia Pty Ltd.

Ingredient Name

brolucizumab

Empowering clinical research with data-driven insights and AI-powered tools.